Expression of hypoxia-inducible factor-1 alpha,hexokinase-Ⅱ and lactate dehydrogenase-Ⅴ in hepatocellular carcinoma and their biological significance
JIANG Xiao-zhong1;YAN Lü-nan2;SUN Guang-yun1;ZHAO Shao-yong1;GU Ji-min1;LEI Kai-jian1; ZHU Yong1;WANG Chang-song1 1.Second People’s Hospital of Yibin;Yibin 644000;P.R.Chian 2.Department of Liver Surgery;West China Hospital;Sichuan University;Chengdu 610041;P.R.Chian

..............page:41-44,48

Expression of SNCG in cervical carcinoma tissues and its relationship with clinical pathological features
SHI Song-qing1;WANG De-shang2 1.Department of Pathology;Zhejiang Red Cross Hospital of Cixi;Cixi 315300;P.R.China 2.Department of Pathology;Clinical Pathology Diagnosis Center of Ningbo;Ningbo 315010;P.R.China

..............page:45-48

Clinical pathology feature analysis of breast phyllodes tumor
CHEN Wen-jing1;ZHANG Jiang-yu1;ZHU Wen-jing1;DU Wei2;LIU Jiong3;GAO Hong-yi1;WU Kun-he1 1.Department of Pathology;Guangdong Women and Children Hospital;Guangzhou Medical College; Guangzhou 510010;P.R.China 2.Department of Pathology;Hunan Changde First People’s Hospital;Changde 415003;P.R.China 3.Department of Pathology;Beijing Aerospace Hospital;Beijing 100076;P.R.China

..............page:49-52

Diagnostic and prognostic value of RASSF1A and APC gene methylation in plasma of liver cancer patients
ZHAO Hui-jin;LI Sheng-mian;ZHANG Hui-jing;GUO Zhan-jun;FAN Hai-yan;YANG Guang-run; WANG Le;ZHANG Ning Department of Gastroenterology;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;P.R.China

..............page:53-57

Hypofractionated three-dimensional conformal radiotherapy plus transcatheter arterial chemoembolization for primary liver cancer
PAN Ping-sheng;ZOU Yu-bin;WAN Lin-lin;MEI Hua;CHEN Li-ping;LI Xiao-bing Department of Oncology;Xinyu People’s Hospital;Xinyu 338000;P.R.China

..............page:58-60

Meta-analysis of chemotherapy combined with thermotherapy for esophageal carcinoma
LI Zheng1;2;MI Deng-hai1;2;3;YANG Ke-hu1;2;CAO Nong2;TIAN Jin-hui1;WANG Dao-ying1;MA Bin1 1.Evidence Based Medicine Center of Lanzhou University;Lanzhou 730000;P.R.China 2.Department of General Surgery;First Clinical Medicine College of Lanzhou University;Lanzhou 730000;P.R.China 3.Department of Oncology;Second People’s Hospital of Gansu Province;Lanzhou 730000;P.R.China

..............page:61-66

ru xian he jia zhuang xian ji xiong gu duo yuan fa e xing zhong liu yi li zhen liao qi shi
zheng mei zhu zheng gang zuo wen shu yang li yang ben liu yan song yu zhi yong

..............page:67-71,74

Compare of characters of the re-transplantation tumor in vivo from the CD133 positive and CD133 negative glioma
LIU Xiao-zhi;ZHAO Yu-jun;JIANG Zhong-min;YANG Bin;WANG Liang;WANG Wei;LIU Zhen-lin Fifth Central Hospital of Tianjin;Tianjin 300450;P.R.China

..............page:1-4

fang she zhi liao gan hai mian zhuang xue guan liu 22 li bao gao
han shou yun xia huo sheng zhang yu hai gao yang wu dian jiu

..............page:72-74

Role and mechanism of HPV16 E7 in apoptosis induced by TNF-α in esophageal cancer cell line
ZHU hong-xia1;ZHOU Xiao-bo2;LIU Mei1;QUAN Lan-ping1;XU Ning-zhi1 1.Laboratory of Cellular and Molecular Biology;Cancer Institute;Chinese Academy of Medical Sciences; Beijing 100021;P.R.China 2.Functional Respiratory Genetics Laboratory;Brigham and Women’s Hospital;Medical College of Harvard Univrsity;Boston 02115;USA

..............page:5-9

Relationship between genetic polymorphisms of CYP1A1,NQO1 and EPHX1 and susceptibility to bladder cancer
FU Jing1;CHEN Bi-cheng2 1.Department of Urology;Shaoxing Second Hospital;Shaoxing 312000;P.R.China 2.Surgical Laboratory;First Affiliated Hospital of Wenzhou Medical College;Wenzhou 325000;P.R.China

..............page:10-14

Epithelial to mesenchymal transition and microRNA-200 with tumor chemoresistance
ZHENG Zhi-kun;LIU Wen-chao Department of Oncology;Xijing Hospital;Fourth Military Medical University;Xi’an;710032;P.R.China

..............page:75-80

Inhibition effect to colorectal cancer induced by synergistic usage of celecoxib and 5-FU and its mechanism
ZHANG De-qing;ZHU Jian-hong;CHEN Wei-chang Department of Digestion Internal Medicine;First Affiliated Hospital;Suzhou University;Suzhou 215006;P.R.China

..............page:15-20

zhong hua zhong liu fang zhi za zhi gao yue

..............page:81-82

Antitumor activity and molecular mechanism of Gefitinib in human glioma cell line U251
OUYANG Jin-ling1;CHEN Nan-jiang1;LIU Yun-cong1;LIAO Jia-qun1;WEI Hong2;LI Hang1 1.Department of Oncology;Guizhou People’s Hospital;Guiyang 550002;P.R.China 2.Department of Microbiology;Guiyang Medical College;Guiyang 550004;P.R.China

..............page:21-26

Effect of nanometer realgar Interfeing on A549 lung cancer cell proliferation and its mechanism
QI Yuan-fu;LI Hui-jie;LIU Zhai-dong Department of Oncology;Affiliated Hospital of Shandong University of TCM;Jinan 250011;P.R.China

..............page:27-30

Effects of cotransfection of two sites of STAT5A-targeting shRNA expression vectors on proliferation and apoptosis of human hepatocellular carcinoma cell line HepG2
ZENG Yong-qiu1;YANG Hua-xiu2;CAO Yang1;LIU Lan1;SHUI Qing-lin1 1.Luzhou Medical College;Luzhou 646000;P.R.China 2.Department of Hepatopathy;Hospital Affiliated to Luzhou Medical College;Luzhou 646000;P.R.China

..............page:31-35

Effects on proliferation and apoptosis of HepG2 cell lines by antisense antisense oligodeoxynucleotide targeted apollon combind with matrine
HE Jin-hua;LI Yu-guang;HANG Ze-ping;XIE Xing-yi;CHEN Wu-jia;HUANG Guo-xian Department of Laboratory;Panyu Center Hospital;Guangzhou 511400;P.R.China

..............page:36-40

zhong hua zhong liu fang zhi za zhi 2013 nian zheng ding qi shi

..............page:83

huan ying ding yue bai xue bing lin ba liu za zhi

..............page:83

huan ying ding yue zhong liu yan jiu yu lin chuang za zhi

..............page:84

zhong guo zhong liu wai ke za zhi zheng gao zheng ding qi shi

..............page:84

zhong hua zhong liu fang zhi za zhi zhu bian yu jin ming yuan shi jian jie

..............page:5